Oxcarbazepine

Oxcarbazepine
Product Description

Oxcarbazepine is a keto analogue of Carbamazepine and, like the parent drug, is a potent anticonvulsant used alone or in combination with other agents in the therapy of poartial seizures. Oxcarbazepine is a dibenzazepine carboxamide derivative with an anticonvulsant property. As a prodrug, oxcarbazepine is converted to its active metabolite, 10-monohydroxy. Although the mechanism of action has not been fully elucidated, electrophysiological studies indicate this agent blocks voltage-gated sodium channels, thereby stabilizing hyper-excited neural membranes, inhibiting repetitive neuronal firing, and decreasing the propagation of synaptic impulses.

CTX LifeSciences Pvt. Ltd.

  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer
Specifications
  • CAS Registry Number
    28721-07-5
  • Supplied from
    India

CTX LifeSciences Pvt. Ltd.

  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Generic APIs producer
Intermediates Manufacturer

More Products from CTX LifeSciences Pvt. Ltd. (29)

  • Brexpiprazole

    Product Brexpiprazole

    Brexpiprazole API is a medication used for the treatment of major depressive disorder, schizophrenia, and agitation associated with dementia due to Alzheimer’s disease. It is an atypical antipsychotic.
  • Saxagliptin

    Product Saxagliptin

    Saxagliptin is used along with diet and exercise to lower blood sugar levels in patients with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Saxagliptin is in a class of medications called dipeptidyl peptidase-4 (dpp-4) inhibitors.
  • Vildagliptin

    Product Vildagliptin

    Vildagliptin is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of Glucagon-like peptide-1(GLP-1) and Glucose-dependent insulinotropic polypeptide(GIP) by DPP-4, allowing GLP-1 and GIP to potentiat...
  • Linagliptin

    Product Linagliptin

    Linagliptin is in a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors.
  • Ticagrelor

    Product Ticagrelor

    CTX Manufacturer Form - II

    O DMF available.
    CEP Approved.




    CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
    API/Substances covered by patent are not offered to the countrie...
  • Hydrochlorothiazide

    Product Hydrochlorothiazide

    Hydrochlorothiazide is a benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxidesubstituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. It has a role as a xenobiotic, ...
  • Metoprolol Succinate

    Product Metoprolol Succinate

    Metoprolol Succinate is the succinate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol succinate antagonizes beta 1-adrenergic receptors in the myocardium, thereby ...
  • Rosuvastatin Calcium

    Product Rosuvastatin Calcium

    Rosuvastatin Calcium is the calcium salt form of rosuvastatin, a statin with antilipidemic activity. Rosuvastatin selectively and competitively binds to and inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG...
  • Eslicarbazepine acetate

    Product Eslicarbazepine acetate

    Eslicarbazepine acetate is the acetate ester, with S configuration, of licarbazepine. An anticonvulsant, it is approved for use in Europe and the United States as an adjunctive therapy for epilepsy. It has a role as an anticonvulsant. It is an acetate ester, a dibenzoazepine, a carboxamide and a ...
  • Deferasirox

    Product Deferasirox

    Deferasirox is a synthetic, orally bioavailable, achiral, tridentate triazole derived from salicylic acid with iron-chelating activity. Deferasirox chelates iron at a 2:1 (ligand:iron) ratio. Because of its oral availability and long plasma half-life, this agent may be superior to&...
  • 4-Amino-6-chlorobenzene-1,3-disulfonamide (CADS)

    Product 4-Amino-6-chlorobenzene-1,3-disulfonamide (CADS)

    CTX offers a wide range of intermediates which includes 5-chloroaniline-2,4-disulfonamide (CADS). API- Hydrochlorothiazide. Contact us for more information.
  • Acetazolamide

    Product Acetazolamide

    Acetazolamide is a sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. Acetazolamide is a non-competitive inhibitor of carbonic anhydrase, an enzyme found in cells in the proximal tube of the kidney, the eye, and glial cells. Inhibition of this enzyme in the kidney prevents e...

CTX LifeSciences Pvt. Ltd. resources (1)

  • Video CTX Lifesciences - Your Preferred API, Intermediates Manufacturing & CDMO Partner from India.

    CTX Lifesciences, a vertically integrated Active Pharmaceutical Ingredient (API ) and intermediates manufacturing company supplying & exporting its products across 87 countries. It was established in the year of 2004 in Surat, India and is a part of family owned $600 Million group. This Facility is having over 1000 KL reaction volume and is spread across 38 acres land with sufficient area for expansion. The Active Pharmaceutical Ingredient (API ) products manufactured are backward integrated into intermediates and Key Starting Materials( KSM ), allowing better controls on quality of the products and supply reliability for our customers. This facility is compliant and approved by USFDA, EUGMP, Health Canada, ANVISA, RUGMP, KFDA, COFEPRIS & Iran MOH. The facility is having excellent EHS Management capabilities and certified with ISO 14001:2015 , ISO 45001:2018. This facility is also Ecovadis Rated and Pharmaceutical Supply Chain Initiative ( PSCI ) Audited. Driven...